Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme.

MLA

Moura Silveira, Marcelle, et al. “Health Impact and Cost-Effectiveness of Introducing the Vaccine (Bexsero) against MenB Disease into the Brazilian Immunization Programme.” Vaccine, vol. 37, no. 45, Oct. 2019, pp. 6783–86. EBSCOhost, https://doi.org/10.1016/j.vaccine.2019.09.062.

APA

Moura Silveira, M., McBride, A. J. A., & Trotter, C. L. (2019). Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme. Vaccine, 37(45), 6783–6786. https://doi.org/10.1016/j.vaccine.2019.09.062

Chicago

Moura Silveira, Marcelle, Alan J A McBride, and Caroline L Trotter. 2019. “Health Impact and Cost-Effectiveness of Introducing the Vaccine (Bexsero) against MenB Disease into the Brazilian Immunization Programme.” Vaccine 37 (45): 6783–86. doi:10.1016/j.vaccine.2019.09.062.